Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Will ink accord with WHO to popularise AYUSH globally: Minister
India's AYUSH Minister Sripad Yesso Naik on Sunday said the ministry will ink an agreement with the World Health Organization to popularise AYUSH system of medicine at a global level.

[adsense:336x280:8701650588]
- Read more about Antibiotics can reduce appendicitis surgeries
Using antibiotics as the primary treatment for appendicitis does not increase the risk for complications at least in the first year and can significantly reduce the number of surgeries by 92 percent within the first month of diagnosis, finds a new study.
- Read more about Birth control pill linked to reduced knee injury
Women who take the birth control pill, which lessens and stabilises estrogen levels, are less likely to suffer serious knee injuries, suggests new research.
- Read more about Ketamine abuse can permanently damage your bladder
Researchers have found that ketamine, often abused as a recreational drug, has the potential to damage the bladder permanently and in worst cases it will lead to its removal.
- Read more about FDA approves Bayer's KOVALTRY® antihemophilic factor (Recombinant)
The U.S. Food and Drug Administration has approved Bayer's KOVALTRY® Antihemophilic Factor (Recombinant), an unmodified, full-length factor VIII compound for the treatment of hemophilia A in children and adults. The approval is based on results from the LEOPOLD (Long-Term Efficacy Open-Label Program in Severe Hemophilia A Disease) clinical trials, which supported the approval of KOVALTRY for routine prophylaxis to reduce the frequency of bleeding episodes.
- Read more about Amgen Wins Patent case on repatha® (Evolocumab)
Amgen announced that a Delaware jury delivered a verdict in Amgen's favor in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).
- Read more about Chugai receives orphan drug designation for Tocilizumab
Chugai Pharmaceutical Co., Ltd. announced that it received from the Minister of Health, Labour and Welfare, a notification of orphan drug designation for human anti-human IL-6 receptor monoclonal antibody "tocilizumab," a drug under development for treatment of systemic scleroderma.
- Read more about GSK’s Advair® Diskus® achieves primary endpoint in LABA safety study of children aged 4-11 years
GlaxoSmithKline plc announced results from the paediatric ‘LABA’ (long acting beta2-agonist) safety study. VESTRI (SAS115358) compared Advair® Diskus® (FSC), a combination of the LABA, salmeterol, and the inhaled corticosteroid (ICS), fluticasone propionate (FP), to FP monotherapy in children aged 4 – 11 years. The study assessed the composite endpoint of serious asthma-related events (deaths, intubations or hospitalisations).
- Read more about Orexigen and Takeda announce Orexigen's Acquisition of all rights to CONTRAVE® in United States
Orexigen Therapeutics, Inc. and Takeda Pharmaceuticals U.S.A., Inc., announced they have agreed to terminate the Amended and Restated Collaboration Agreement for CONTRAVE® (naltrexone HCl / bupropion HCl), the market leading national branded prescription treatment option for certain overweight and obese adults for chronic weight management. Completion of the transaction is subject to the parties’ receipt of clearance under the Hart-Scott-Rodino Antitrust Improvement Act (“HSR Act”).
- Read more about How gut keeps bacteria from escaping
A team of British researchers has discovered how the immune system stops bacteria in our gut from leaking into the blood stream that may help in treatment and prevention of life threatening infections.